Tirzepatide appears to have a peculiar impact on atherogenic dyslipidemia compared to GLP-1R monoagonists, with a preferential benefit on triglyceride levels [78, 79]
The UK RECOVERY trial has shown survival benefit with dexamethasone in ventilated patients with severe respiratory complications from COVID-19 [29]
And these arent experimental drugs, for what its worth
There were some limitations to the study, such as a lack of blinding and the use of a non-validated symptom questionnaire During the study, people receiving L-carnitine and selenium were significantly more likely to experience a spontaneous remission (63% vs
Report suspected adverse drug reactions via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store
Many successful patients maintain results on 1.6 mg or 1.8 mg indefinitely, proving that the marketed maximum isn't required for lasting success